000 | 01407 a2200385 4500 | ||
---|---|---|---|
005 | 20250511214442.0 | ||
264 | 0 | _c19900731 | |
008 | 199007s 0 0 eng d | ||
022 | _a0022-3565 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNishino, S | |
245 | 0 | 0 |
_aEffects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep. _h[electronic resource] |
260 |
_bThe Journal of pharmacology and experimental therapeutics _cJun 1990 |
||
300 |
_a1145-52 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdrenergic alpha-Agonists _xmetabolism |
650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 |
_aCataplexy _xdrug therapy |
650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 |
_aHemodynamics _xdrug effects |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aReceptors, Adrenergic, alpha _xdrug effects |
650 | 0 | 4 |
_aSleep, REM _xdrug effects |
650 | 0 | 4 |
_aYohimbine _xmetabolism |
700 | 1 | _aHaak, L | |
700 | 1 | _aShepherd, H | |
700 | 1 | _aGuilleminault, C | |
700 | 1 | _aSakai, T | |
700 | 1 | _aDement, W C | |
700 | 1 | _aMignot, E | |
773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 253 _gno. 3 _gp. 1145-52 |
|
999 |
_c1978934 _d1978934 |